Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study

INTRODUCTION: Ascertainment of the pattern and temporal change of biomarkers in preclinical (asymptomatic) sporadic Alzheimer's disease (AD) will increase knowledge about early pathogenesis and facilitate interventional therapeutic trials. METHODS: In this prospective longitudinal study, repeat...

Descripción completa

Detalles Bibliográficos
Autores principales: Stomrud, Erik, Minthon, Lennart, Zetterberg, Henrik, Blennow, Kaj, Hansson, Oskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
CSF Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879483/
https://www.ncbi.nlm.nih.gov/pubmed/27239521
http://dx.doi.org/10.1016/j.dadm.2015.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879483/
https://www.ncbi.nlm.nih.gov/pubmed/27239521
http://dx.doi.org/10.1016/j.dadm.2015.09.002

Ejemplares similares